 |
인쇄하기
취소
|
Yooyoung to introduce Nippon Shinyaku’s NS-126
Yooyoung Pharm and Nippon Shinyaku Co. have recently announced an exclusive license agreement, under which Yooyoung will acquire exclusive rights in Korea to develop and commercialize NS-126, an agent for allergic rhinitis and asthma.
NS-126 is a dry powder form containing a novel steroid compound to be sprayed once daily. It has less skin irritation compared to a liquid form.
Currently, ...
NS-126 is a dry powder form containing a novel steroid compound to be sprayed once daily. It has less skin irritation compared to a liquid form.
Currently, ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.